Analyst Ratings for Collegium Pharmaceutical (COLL)
COLL Rating Summary
COLL Price Target Summary
- Highest: $56.00 (Barclays)
- Lowest: $45.00 (Piper Sandler)
- Average: $49.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$49.50 (+42.9%)
* Over Last 12-Mos
Rating Score: 6.4 / 10
Percentile Rank: 67%
Avg. $ Target:
$49.50 (+42.9%)
* Over Last 12-Mos
Rating Score: 6.4 / 10
Percentile Rank: 67%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/9/2025 | Barclays » Updated 3/19/2026 |
Glen Santangelo | New Coverage | Overweight (N/A) |
56.00 (N/A) |
47.91 (34.64) |
-27.7% | Details |
| 8/11/2025 | H.C. Wainwright » Updated 11/7/2025 |
Brandon Folkes | New Coverage | Buy (N/A) |
46.00 (44.00) |
34.93 (34.64) |
-0.83% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
